Related Experiment Video
Updated: Aug 6, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
V Bagalas1, I Kioumis, P Argyropoulou
1Department of Pulmonary Disease, Aristotle University of Thessaloniki Medical School-G. Papanikolaou Hospital, Exohi, Thessaloniki, 57010, Greece. bagalasv@yahoo.com
Abstract:
Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-alpha (TNF-alpha) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-alpha antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management
